Company
Rapport Therapeutics Inc.
Rapport Therapeutics Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| RAP-219 | Phase 3 | Focal Seizure |
Latest
No recent events.
Follow Rapport Therapeutics Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.